Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient.
Biondani, P
Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology 01 2018 - 286-287 p. digital
Publication Type: Case Reports; Journal Article
1569-8041
10.1093/annonc/mdx548 doi
Carcinoma, Non-Small-Cell Lung--drug therapy
Humans
Liver Transplantation
Lung Neoplasms--drug therapy
Male
Middle Aged
Nivolumab--adverse effects
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology 01 2018 - 286-287 p. digital
Publication Type: Case Reports; Journal Article
1569-8041
10.1093/annonc/mdx548 doi
Carcinoma, Non-Small-Cell Lung--drug therapy
Humans
Liver Transplantation
Lung Neoplasms--drug therapy
Male
Middle Aged
Nivolumab--adverse effects
Programmed Cell Death 1 Receptor--antagonists & inhibitors